Advantages to centralising laboratory services at hVIVO

Clinical field studies are a critical part of the drug development and approval process. They are conducted to evaluate the safety, immunogenicity, and efficacy of a new drug. These studies require careful monitoring, attention to detail, significant logistics, and expertise in laboratory analysis.  Centralising laboratory services can provide many benefits for clinical field studies. In this article, we’ll explore five of the most significant advantages of centralising laboratory services during a clinical field study.

  1. Access to state-of-the-art equipment and technology:

Our hLab services provides our clients with access to the latest equipment and technology, which would be too costly to maintain in-house, while centralising the lab services ensures a consistent readout for multi-site studies. 

hVIVO plc (formerly Open Orphan plc) is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and antivirals using human challenge clinical trials, providing end-to-end early clinical development services for its broad and long-standing client base of biopharma companies.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    X
    LinkedIn
    hVIVO plc

    More articles like this

    hVIVO plc

    hVIVO fast-tracks drug trials and draws big pharma in

    In a sector where timelines can stretch over decades and budgets run into billions, hVIVO is rewriting the rules—delivering clinical insight in a fraction of the time and attracting heavyweight pharmaceutical partners along the way. hVIVO